![](https://www.healthcare-economist.com/wp-content/uploads/2024/06/prospect-theory-utility.png)
Kahneman and Tversky’s prospect theory They postulate that individuals have loss aversion. What is loss aversion?
This means that people experience losses more intensely than gains of the same magnitude; For example, the psychological impact of losing a certain amount of money is greater than the pleasure derived from winning that same amount. A key question is how much Do individuals experience gains more intensely than losses?
To formalize things, prospect theory assumes the following utility function:
The most cited estimates for these parameters come from Tversky and Kahneman (1992)In that paper, they found that loss aversion λ=2.25 and α=β=0.88. We can graph the utility function with this parameterization in the following graph as shown below.
![](https://www.healthcare-economist.com/wp-content/uploads/2024/06/loss-aversion-graph-1024x568.png)
A key issue, however, is that Tversky and Kahneman (1992) Estimates of loss aversion were obtained from a single study of 25 graduate students at an elite American university. To what extent can these results be generalized? Is there a better estimate of loss aversion?
A paper Brown et al (2024) aims to answer this question by conducting a meta-analysis of loss aversion estimates from all studies published between 1992 and 2017. They found 607 empirical estimates of loss aversion across 150 articles. The studies came from a variety of disciplines (e.g., economics, psychology, neuroscience) and a variety of data types. Most studies (53%) were based on a laboratory experiment design, but 26.5% of the identified articles came from a field experiment with other field data; 42% of the studies came from Europe and 30% from North America.
The unadjusted results (shown below) estimated a median loss aversion of 1.69 and a mean loss aversion of 1.97. After applying a random effects meta-analytic distribution, the mean loss aversion coefficient was found to be 1.955 with a 95% probability that the actual value is between 1,820 and 2,102.
![](https://www.healthcare-economist.com/wp-content/uploads/2024/06/loss-aversion-results.png)
These results are somewhat lower, but not very different from those Tversky and Kahneman (1992) Estimate 2.25. We can also compare the results with two previous meta-analysis studies on loss aversion. Neumann and Böckenholt 2014– which examined consumer aversion using 33 studies on consumer brand choice – reported a base model estimate of λ = 1.49 and an “enhanced model” estimate of λ = 1.73; Walasek, Mullett and Stewart (2018)– which examined 17 studies of financial lotteries with wins and losses – estimated that λ = 1.31. In summary, the results of Brown et al. They are higher than previous estimates, but lower than those of Tversky and Kahneman.
You can read the full article here.
Key references
- Brown, Alexander L., Taisuke Imai, Ferdinand M. Vieider, and Colin F. Camerer. “A meta-analysis of empirical estimates of loss aversion.” Magazine of economic literature 62, No. 2 (2024): 485-516.
- Neumann, Nico, and Ulf Böckenholt. 2014. “A Meta-Analysis of Loss Aversion in Product Choice.” Journal of Retailing 90 (2): 182–97.
- Tversky, Amos and Daniel Kahneman. 1992. “Advances in Prospect Theory: Cumulative Representation of Uncertainty.” Journal of Risk and Uncertainty 5(4): 297–323.
- Walasek, Lukasz, Timothy L. Mullett, and Neil Stewart. 2018. “A meta-analysis of loss aversion in risk contexts.” http://dx.doi.org/10.2139/ssrn.3189088.